Journal Title：Annals Of Oncology

Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.

Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.

《腫瘤學年鑒》是歐洲腫瘤醫(yī)學學會和日本腫瘤醫(yī)學學會的期刊，提供快速、高效的同行評審出版物，內容涉及創(chuàng)新癌癥治療或與腫瘤學和精準醫(yī)學相關的轉化工作。

主要關注點包括：全身抗癌治療（特別關注分子靶向藥物和新型免疫療法）、隨機試驗（包括陰性試驗）、頂級指南以及目前作為個性化醫(yī)療關鍵組成部分出現的新興領域，如分子病理學、生物信息學、現代統(tǒng)計學和生物技術。如果放射治療、外科和兒科手稿與上述領域之一有明顯的互動或具有范式轉變，則可以考慮。

Annals Of Oncology創(chuàng)刊于1990年，由Oxford University Press出版商出版，收稿方向涵蓋醫(yī)學 - 腫瘤學全領域，在行業(yè)領域中學術影響力很大，屬于TOP期刊，國際一流期刊，關注度和專業(yè)度非常高，所以對原創(chuàng)文章要求創(chuàng)新性很高，過審難度很高，如果您有志于TOP期刊，建議關注此刊。平均審稿速度 很快,2-3周 ，影響因子指數56.7，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。